SAN JOSE, Calif., Oct. 4, 2011 /PRNewswire/ -- ICU Medical, Inc. (NASDAQ: ICUI) announced it is launching the Neutron™ needlefree catheter patency device with constant neutral pressure today at the Association for Vascular Access Annual Scientific Meeting in San Jose, CA. Neutron is the world's first and only device with FDA 510k clearance to claim the ability to prevent fluid displacement during an IV bag run-dry, infusion pump stop, or patient vascular pressure changes caused by coughing, sneezing or movement — all of which have been associated with loss of catheter patency. Results of early clinical use and pre-launch testing of the Neutron device have been so favorable, that ICU Medical is offering its customers a $100,000 Performance Guarantee. If a health care facility does not experience a reduction in catheter occlusion rates in the first three months after converting all of its central IV lines to the Neutron, ICU Medical will pay that facility $100,000.
Blood reflux into a catheter is a common problem in IV therapy, and has been shown to contribute to numerous complications including biofilm formation, clotting, and intraluminal thrombotic occlusions that can lead to increased healthcare costs and potential delays in essential treatment. In three months of clinical use at Sharp Home Infusion Services in San Diego, CA — part of the Malcolm Baldridge Quality Award-winning Sharp Health System — a change to the Neutron device from the CareFusion MaxPlus MV connector led to a 70% reduction in occlusion rates, according to Lori Rhoades, RN, BSN, NE-BC, Director of Nursing & Patient Care Services at Sharp Home Infusion.
"This dramatic decrease in occlusions is particularly significant because home infusion patients are going about their daily activities and generate more movement, which can be a primary cause of b